Clinical data on patients with SCD at cardiac catheterization
. | Age at catheterization, y . | Sex . | Hemoglobin type . | Other diagnoses . | Status . |
---|---|---|---|---|---|
Patients with PHTN | |||||
1 | 23 | F | SS | Deceased | |
2 | 44 | F | SS | Alive | |
3 | 37 | M | SS | Deceased | |
4 | 32 | M | SS | Deceased | |
5 | 40 | F | SS | Alive | |
6 | 28 | F | SS | Alive | |
7 | 33 | F | SS | Deceased | |
8 | 55 | F | SS | ESRD | Deceased |
9 | 21 | F | SS | Alive | |
10 | 47 | M | SC | Stroke-hypertension | Alive |
11 | 27 | F | SS | Pulmonary fibrosis | Alive |
12 | 30 | F | SS | Deceased | |
13 | 30 | F | SS | Deceased | |
14 | 42 | F | SS | Liver cirrhosis | Alive |
15 | 57 | F | SS | ESRD | Deceased |
16 | 37 | M | SC | Deceased | |
17 | 40 | F | SS | ESRD | Deceased |
18 | 26 | F | SS | Deceased | |
19 | 59 | M | SD | Azotemia | Alive |
20 | 37 | M | Sβ+-thalassemia | Pulmonary fibrosis | Alive |
Patients without PHTN | |||||
21 | 21 | F | SS | Hypertension | Alive |
22 | 28 | M | SS | Alive | |
23 | 35 | F | SS | Alive | |
24 | 33 | F | SS | Alive | |
25 | 45 | M | SC | Alive | |
26 | 31 | M | SS | Alive | |
27 | 48 | M | SC | Pulmonary fibrosis | Alive |
28 | 25 | M | SS | Alive | |
29 | 25 | M | SS | Liver cirrhosis | Deceased |
30 | 42 | F | SS | Pulmonary vascular sclerosis | Alive |
31 | 34 | M | SS | HIV+, arrhythmias | Deceased |
32 | 20 | M | SS | Strokes, liver cirrhosis | Deceased |
33 | 21 | M | SS | Alive | |
34 | 21 | M | SS | Alive |
. | Age at catheterization, y . | Sex . | Hemoglobin type . | Other diagnoses . | Status . |
---|---|---|---|---|---|
Patients with PHTN | |||||
1 | 23 | F | SS | Deceased | |
2 | 44 | F | SS | Alive | |
3 | 37 | M | SS | Deceased | |
4 | 32 | M | SS | Deceased | |
5 | 40 | F | SS | Alive | |
6 | 28 | F | SS | Alive | |
7 | 33 | F | SS | Deceased | |
8 | 55 | F | SS | ESRD | Deceased |
9 | 21 | F | SS | Alive | |
10 | 47 | M | SC | Stroke-hypertension | Alive |
11 | 27 | F | SS | Pulmonary fibrosis | Alive |
12 | 30 | F | SS | Deceased | |
13 | 30 | F | SS | Deceased | |
14 | 42 | F | SS | Liver cirrhosis | Alive |
15 | 57 | F | SS | ESRD | Deceased |
16 | 37 | M | SC | Deceased | |
17 | 40 | F | SS | ESRD | Deceased |
18 | 26 | F | SS | Deceased | |
19 | 59 | M | SD | Azotemia | Alive |
20 | 37 | M | Sβ+-thalassemia | Pulmonary fibrosis | Alive |
Patients without PHTN | |||||
21 | 21 | F | SS | Hypertension | Alive |
22 | 28 | M | SS | Alive | |
23 | 35 | F | SS | Alive | |
24 | 33 | F | SS | Alive | |
25 | 45 | M | SC | Alive | |
26 | 31 | M | SS | Alive | |
27 | 48 | M | SC | Pulmonary fibrosis | Alive |
28 | 25 | M | SS | Alive | |
29 | 25 | M | SS | Liver cirrhosis | Deceased |
30 | 42 | F | SS | Pulmonary vascular sclerosis | Alive |
31 | 34 | M | SS | HIV+, arrhythmias | Deceased |
32 | 20 | M | SS | Strokes, liver cirrhosis | Deceased |
33 | 21 | M | SS | Alive | |
34 | 21 | M | SS | Alive |
ESRD indicates end-stage renal disease.